Dabigatran etexilate

被引:7
|
作者
Dubois, Eline A.
Cohen, Adam F.
机构
关键词
ATRIAL-FIBRILLATION; WARFARIN;
D O I
10.1111/j.1365-2125.2010.03644.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:14 / 15
页数:2
相关论文
共 50 条
  • [31] Pharmacogenetics of dabigatran etexilate interindividual variability
    Dimatteo, Claudia
    D'Andrea, Giovanna
    Vecchione, Gennaro
    Paoletti, Oriana
    Cappucci, Filomena
    Tiscia, Giovanni Luca
    Buono, Matteo
    Grandone, Elvira
    Testa, Sophie
    Margaglione, Maurizio
    THROMBOSIS RESEARCH, 2016, 144 : 1 - 5
  • [32] Dabigatran etexilate for prevention of venous thromboembolism
    Eikelboom, John E.
    Weitz, Jeffrey I.
    THROMBOSIS AND HAEMOSTASIS, 2009, 101 (01) : 2 - 4
  • [34] Dabigatran etexilate in people with atrial fibrillation
    Raju, Nina C.
    Hankey, Graeme J.
    BRITISH MEDICAL JOURNAL, 2010, 341
  • [36] A chemometric comparison of different models in fluorescence analysis of dabigatran etexilate and dabigatran
    Wang, Tong
    Liu, Qian
    Long, Wan-Jun
    Chen, An-Qi
    Wu, Hai-Long
    Yu, Ru-Qin
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2021, 246
  • [38] Dabigatran etexilate for venous thromboembolism: a safety evaluation
    Brown, Richard
    Lip, Gregory Y. H.
    Gallego, Pilar
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (05) : 639 - 647
  • [40] Dabigatran etexilate and reduction in serum apolipoprotein B
    Joseph, Philip
    Pare, Guillaume
    Wallentin, Lars
    Connolly, Stuart
    Yusuf, Salim
    Wang, Jia
    Ezekowitz, Michael
    Eikelboom, John
    Siegbahn, Agneta
    Reilly, Paul
    Themeles, Ellison
    Oldgren, Jonas
    HEART, 2016, 102 (01) : 57 - 62